- Home
- LILA vs HRMY Comparison
LILA vs HRMY Comparison
Compare LILA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILA
- HRMY
- Stock Information
- Founded
- LILA 2017
- HRMY 2017
- Country
- LILA Bermuda
- HRMY United States
- Employees
- LILA N/A
- HRMY N/A
- Industry
- LILA Cable & Other Pay Television Services
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- LILA Telecommunications
- HRMY Health Care
- Exchange
- LILA Nasdaq
- HRMY Nasdaq
- Market Cap
- LILA 1.6B
- HRMY 1.5B
- IPO Year
- LILA N/A
- HRMY 2020
- Fundamental
- Price
- LILA $8.14
- HRMY $33.60
- Analyst Decision
- LILA Buy
- HRMY Strong Buy
- Analyst Count
- LILA 2
- HRMY 9
- Target Price
- LILA $9.75
- HRMY $50.44
- AVG Volume (30 Days)
- LILA 340.5K
- HRMY 915.1K
- Earning Date
- LILA 11-05-2025
- HRMY 11-04-2025
- Dividend Yield
- LILA N/A
- HRMY N/A
- EPS Growth
- LILA N/A
- HRMY 50.44
- EPS
- LILA N/A
- HRMY 3.17
- Revenue
- LILA $4,433,000,000.00
- HRMY $825,944,000.00
- Revenue This Year
- LILA $1.35
- HRMY $20.68
- Revenue Next Year
- LILA N/A
- HRMY $15.93
- P/E Ratio
- LILA N/A
- HRMY $10.59
- Revenue Growth
- LILA N/A
- HRMY 21.13
- 52 Week Low
- LILA $4.26
- HRMY $25.52
- 52 Week High
- LILA $8.94
- HRMY $40.93
- Technical
- Relative Strength Index (RSI)
- LILA 52.13
- HRMY 72.04
- Support Level
- LILA $7.85
- HRMY $27.66
- Resistance Level
- LILA $8.94
- HRMY $30.96
- Average True Range (ATR)
- LILA 0.40
- HRMY 1.24
- MACD
- LILA 0.01
- HRMY 0.60
- Stochastic Oscillator
- LILA 43.71
- HRMY 98.16
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.